BRIDGEBIO PHARMA INC - NOTE 2.250% 2/0

Q1 2022 13F Holders as of 3/31/2022

Type / Class
Debt / NOTE 2.250% 2/0
Number of holders
36
Total Principal
625M
Shares change
+605M
Total reported value, excl. options
$307M
Value change
+$298M
Number of buys
34
Price
$0.48
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.